
Udhayvir Grewal/X
Jun 18, 2025, 08:04
Udhayvir Grewal: New in ESMO GI Oncology – Managing Adverse Events in Metastatic Colorectal Cancer
Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, shared a post on X:
“New in ESMO GI Oncology – Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab. Marwan G. Fakih et al
– Practical guidance for managing key AEs with Lonsurf+Bevacizumab.
– Neutropenia
– Hypertension
– Fatigue, nausea, anemia, diarrhea
– Expert-backed strategies to optimize safety + outcomes.”
More posts featuring Udhayvir Grewal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 18, 2025, 08:05
Jun 18, 2025, 08:02
Jun 18, 2025, 07:40
Jun 18, 2025, 07:08